BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17559064)

  • 1. Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor.
    Axén A; Andersson H; Lindeberg G; Rönnholm H; Kortesmaa J; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
    J Pept Sci; 2007 Jul; 13(7):434-44. PubMed ID: 17559064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
    Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
    J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
    Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
    J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.
    Demaegdt H; Lenaerts PJ; Swales J; De Backer JP; Laeremans H; Le MT; Kersemans K; Vogel LK; Michotte Y; Vanderheyden P; Vauquelin G
    Eur J Pharmacol; 2006 Sep; 546(1-3):19-27. PubMed ID: 16919623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11.
    Demaegdt H; Lukaszuk A; De Buyser E; De Backer JP; Szemenyei E; Tóth G; Chakravarthy S; Panicker M; Michotte Y; Tourwé D; Vauquelin G
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):77-86. PubMed ID: 19643163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
    Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
    Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of "AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells.
    Demaegdt H; Gard P; De Backer JP; Lukaszuk A; Szemenyei E; Tóth G; Tourwé D; Vauquelin G
    Mol Cell Endocrinol; 2011 Jun; 339(1-2):34-44. PubMed ID: 21457753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
    Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
    J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.
    Stragier B; Demaegdt H; De Bundel D; Smolders I; Sarre S; Vauquelin G; Ebinger G; Michotte Y; Vanderheyden P
    Brain Res; 2007 Feb; 1131(1):97-105. PubMed ID: 17169335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP).
    Demaegdt H; De Backer JP; Lukaszuk A; Tóth G; Szemenyei E; Tourwé D; Vauquelin G
    Fundam Clin Pharmacol; 2012 Apr; 26(2):194-7. PubMed ID: 21477268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase.
    Nikolaou A; Van den Eynde I; Tourwé D; Vauquelin G; Tóth G; Mallareddy JR; Poglitsch M; Van Ginderachter JA; Vanderheyden PM
    Eur J Pharmacol; 2013 Feb; 702(1-3):93-102. PubMed ID: 23376157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.
    Demaegdt H; Vanderheyden P; De Backer JP; Mosselmans S; Laeremans H; Le MT; Kersemans V; Michotte Y; Vauquelin G
    Biochem Pharmacol; 2004 Sep; 68(5):885-92. PubMed ID: 15294451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory.
    Albiston AL; Fernando RN; Yeatman HR; Burns P; Ng L; Daswani D; Diwakarla S; Pham V; Chai SY
    Neurobiol Learn Mem; 2010 Jan; 93(1):19-30. PubMed ID: 19660563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-homo-amino acid scan of angiotensin IV.
    Lukaszuk A; Demaegdt H; Szemenyei E; Tóth G; Tymecka D; Misicka A; Karoyan P; Vanderheyden P; Vauquelin G; Tourwé D
    J Med Chem; 2008 Apr; 51(7):2291-6. PubMed ID: 18386881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
    Weiland F; Verspohl EJ
    Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin IV/AT4 receptor.
    Chai SY; Fernando R; Peck G; Ye SY; Mendelsohn FA; Jenkins TA; Albiston AL
    Cell Mol Life Sci; 2004 Nov; 61(21):2728-37. PubMed ID: 15549174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
    Andersson H; Demaegdt H; Johnsson A; Vauquelin G; Lindeberg G; Hallberg M; Erdelyi M; Karlen A; Hallberg A
    J Med Chem; 2011 Jun; 54(11):3779-92. PubMed ID: 21476495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
    Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
    J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP.
    Wallis MG; Lankford MF; Keller SR
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1092-102. PubMed ID: 17684103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
    Lukaszuk A; Demaegdt H; Feytens D; Vanderheyden P; Vauquelin G; Tourwé D
    J Med Chem; 2009 Sep; 52(18):5612-8. PubMed ID: 19757839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.